LONDON, ON , March 14, 2023 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSXV: NDVA), announced that it has received notification from Health Canada (the " Notice ") of its determination that certain of its lozenges have been improperly classified as an "extract" rather than an "edible" under applicable cannabis regulations. Heath Canada has requested that Indiva cease production of the lozenges. The lozenges subject... Read More